China Bispecific Antibodies Market Size & Outlook, 2025-2031
China Bispecific Antibodies Market Size
According to Straits Research analysis, The China Bispecific Antibodies Market was valued at USD 296.47 Million in 2024 and is projected to reach USD 858.37 Million by 2031, expanding at a CAGR of 17.2% during the forecast period. Primary drivers of demand include significant advancements in biotechnological research and cancer therapeutics. Exploring potential for treating diseases such as cardiovascular diseases, autoimmune diseases and cancer, the market is expected to witness tremendous increase. The advent of technological advancements such as next-generation sequence technology contributes significantly to the expansion. Opportunities lie in developing sustainable, green production methods and utilizing export potential. As China solidifies its position as a global leader in the biopharmaceutical sector, the future of its Bispecific Antibodies market remains promising.
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Bispecific Antibodies Market Highlights
- By 2024, Bi-specific T-cell engager represented the largest share of the Type market size.
- Bi-specific T-cell engager is expected to remain the key growth driver within Type, registering the fastest CAGR during the forecast period.
- China contributed 5.38% to the global bispecific antibodies market size in 2024.
- By 2031, United States is forecasted to remain the largest global market for bispecific antibodies market.
- In Asia Pacific, China is projected to capture the leading share of market by 2031.
- Among Asia Pacific markets, India is expected to post the fastest growth, reaching USD 454.85 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 296.47 Million |
| Market Size In 2031 | USD 858.37 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 17.2% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
China Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
